![]() |
同义名 : | - |
CAS号 : | 916232-21-8 | |
货号 : | A1061932 | |
分子式 : | C28H19FN2O4 | |
纯度 : | 99%+ | |
分子量 : | 466.46 | |
MDL号 : | MFCD30182334 | |
存储条件: |
Pure form Sealed in dry, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | Nuclear factor-kappa B (NF-κB) is known to regulate the expression of divergent genes involved not only in immune and inflammatory responses but also in cell death and survival. IκBα is the protein inhibitor of NF-κB whose phosphorylation is catalyzed by an IκB kinase (abbreviated IKK). GS143 is a selec¬tive IκBα ubiquitination inhibitor with an IC50 of 5.2 μM for SCFβTrCP1-mediated IκBα ubiquitylation. GS143 suppressed the transcription of TNFα-induced NF-κB with a mean IC50 value of 10.5 μM. GS143 also inhibited TNFα-induced expression of ICAM-1 in HT-29 colon cancer cells with an IC50 value of 6.1 μM. The production levels of TNFα and IL-1β in LPS-activated THP-1 cells were inhibited by GS143 with IC50 values of 5.3 μM and 2.1 μM, respectively[2]. In BALB/c mice, intranasal administration of GS143 (16-32 μg/kg) treatment suppressed antigen-induced NF-κB activation in the lung of sensitized mice. GS143 treatment also inhibited antigen-induced eosinophil and lymphocyte recruitment into the airways and the expression of Th2 cytokines and eotaxin in the airways[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.14mL 0.43mL 0.21mL |
10.72mL 2.14mL 1.07mL |
21.44mL 4.29mL 2.14mL |
参考文献 |
---|